Back to Journals » Clinical and Experimental Gastroenterology » Volume 11
Original Research
A study of the circulating fibroblast growth factor 21 as a novel noninvasive biomarker of hepatic injury in genotype-4 chronic hepatitis C: Egyptian patients and their response to direct-acting antiviral agents
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,542 | Dovepress* | 6,261+ | 780 | 7,041 | |
PubMed Central* | 281 | 84 | 365 | ||
Totals | 6,542 | 864 | 7,406 | ||
*Since 24 October 2018 |
View citations on PubMed Central and Google Scholar